Seeking Alpha

Alnylam Pharmaceuticals (ALNY): Q2 EPS of -$0.25 misses by $0.04. Revenue of $20.9M (+1.5% Y/Y)...

Alnylam Pharmaceuticals (ALNY): Q2 EPS of -$0.25 misses by $0.04. Revenue of $20.9M (+1.5% Y/Y) in-line. Shares -4.7% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector